These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18355689)

  • 1. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.
    Antenor-Dorsey JA; Markham J; Moerlein SM; Videen TO; Perlmutter JS
    Nucl Med Biol; 2008 Apr; 35(3):335-41. PubMed ID: 18355689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
    Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
    Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
    Moerlein SM; Perlmutter JS; Markham J; Welch MJ
    J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
    Moerlein SM; Perlmutter JS; Welch MJ
    Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol.
    Eisenstein SA; Antenor-Dorsey JA; Gredysa DM; Koller JM; Bihun EC; Ranck SA; Arbeláez AM; Klein S; Perlmutter JS; Moerlein SM; Black KJ; Hershey T
    Synapse; 2013 Nov; 67(11):748-56. PubMed ID: 23650017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
    Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
    J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
    Otsuka T; Ito H; Halldin C; Takahashi H; Takano H; Arakawa R; Okumura M; Kodaka F; Miyoshi M; Sekine M; Seki C; Nakao R; Suzuki K; Finnema S; Hirayasu Y; Suhara T; Farde L
    J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
    Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
    Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
    Suehiro M; Dannals RF; Scheffel U; Stathis M; Wilson AA; Ravert HT; Villemagne VL; Sanchez-Roa PM; Wagner HN
    J Nucl Med; 1990 Dec; 31(12):2015-21. PubMed ID: 2148346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding.
    Moerlein SM; Banks WR; Parkinson D
    Int J Rad Appl Instrum A; 1992 Jul; 43(7):913-7. PubMed ID: 1321101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates.
    Antenor-Dorsey JA; Laforest R; Moerlein SM; Videen TO; Perlmutter JS
    Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):771-8. PubMed ID: 18071701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.
    Nikolaus S; Larisch R; Beu M; Forutan F; Vosberg H; Müller-Gärtner HW
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):390-5. PubMed ID: 12634967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?
    Karimi M; Moerlein SM; Videen TO; Luedtke RR; Taylor M; Mach RH; Perlmutter JS
    Mov Disord; 2011 Jan; 26(1):100-6. PubMed ID: 20960437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
    Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
    Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.